Cargando…
Targeting the Serine Pathway: A Promising Approach against Tuberculosis? †
Tuberculosis is still the leading cause of death by a single infectious agent. Effective chemotherapy has been used and improved since the 1950s, but strains resistant to this therapy and most antibacterial drugs on the market are emerging. Only 10 new drugs are in clinical trials, and two of them h...
Autores principales: | Haufroid, Marie, Wouters, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630544/ https://www.ncbi.nlm.nih.gov/pubmed/31052291 http://dx.doi.org/10.3390/ph12020066 |
Ejemplares similares
-
Identification and Repurposing of Trisubstituted Harmine Derivatives as Novel Inhibitors of Mycobacterium tuberculosis Phosphoserine Phosphatase
por: Pierson, Elise, et al.
Publicado: (2020) -
Promise and peril in nanomedicine: the challenges and needs for integrated systems biology approaches to define health risk
por: Halappanavar, Sabina, et al.
Publicado: (2017) -
Oral bacillus Calmette-Guérin vaccine against tuberculosis: why
not?
por: Monteiro-Maia, Renata, et al.
Publicado: (2014) -
E-Cigarette as a Harm Reduction Approach among Tobacco Smoking Khat Chewers: A Promising Bullet of Multiple Gains
por: Kassim, Saba, et al.
Publicado: (2016) -
The Emergence of Endophytic Microbes and Their Biological Promise
por: Strobel, Gary
Publicado: (2018)